(Q36285947)

13 August 2017

1 reference

title

New management approaches for gastroparesis (English)

1 reference

13 August 2017

1 reference

Christopher K Rayner

1

1 reference

13 August 2017

Michael Horowitz

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Nature Reviews Gastroenterology & Hepatology

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

454-62; quiz 493

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpgasthep0283

13 August 2017

exact match

0 references

cites work

Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Diabetic gastropathy and prokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Predictors of delayed gastric emptying in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Impacts and patterns of disturbed gastrointestinal function in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Role and integration of mechanisms controlling gastric emptying

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Gastric emptying in diabetes: clinical significance and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Relationships of upper gastrointestinal motor and sensory function with glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Measurement of gastrointestinal motility in the GI laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Assessment of gastric accommodation: overview and evaluation of current methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Gastroparesis: prevalence, clinical significance and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Effects of low doses of erythromycin on the 13C Spirulina platensis gastric emptying breath test and electrogastrogram: a controlled study in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Review article: cardiac adverse effects of gastrointestinal prokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Cisapride vs metoclopramide. An acute study in diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Management of the patient with gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Novel surgical treatment and gastric pathology in diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Long-term outcome after gastrectomy for intractable diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Idiopathic and Diabetic Gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Pyloric dysfunction in diabetics with recurrent nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Pathophysiology of functional dyspepsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Role of impaired gastric accommodation to a meal in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Diabetic gastroparesis: an abnormality of gastric emptying of solids

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Managing functional bowel disorders from the top down: lessons from a well-designed treatment trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Botulinum toxin for the treatment of gastroparesis: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Gastric pacing improves emptying and symptoms in patients with gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Gastric electrical stimulation for medically refractory gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Microprocessor-controlled movement of solid gastric content using sequential neural electrical stimulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Changes in Gastric Emptying in Recipients of Successful Combined Pancreas-Kidney Transplants

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Natural history of diabetic gastroparesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0283

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0283

1 reference

13 August 2017

1 reference